AGIO: Agios Pharmaceuticals, Inc. Stock

by  •  • Comments Off on AGIO: Agios Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,855.25
Enterprise Value ($M) 1,779.00
Book Value ($M) 1,540.96
Book Value / Share 26.89
Price / Book 1.20
NCAV ($M) 843.36
NCAV / Share 14.72
Price / NCAV 2.20

Profitability (mra)
Return on Invested Capital (ROIC) 0.42
Return on Assets (ROA) 0.72
Return on Equity (ROE) 0.83

Liquidity (mrq)
Quick Ratio 11.56
Current Ratio 11.90

Balance Sheet (mrq) ($M)
Current Assets 965.60
Assets 1,663.20
Liabilities 122.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 36.50
Operating Income -425.74
Net Income 673.73
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -389.84
Cash from Investing 363.44
Cash from Financing 14.44

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Bb Biotech Ag 6.20 -12.12
02-04 13G/A Farallon Capital Partners, L.P. 9.90 0.24
11-14 13G/A Armistice Capital, Llc 3.88 -37.37
2024-02-14 13G/A Rock Springs Capital Management LP 3.85 -28.18
2024-02-12 13G/A Vanguard Group Inc 9.89 3.61

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2024-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-10 94,854 638,782 14.85
2025-03-07 147,039 556,947 26.40
2025-03-06 117,721 417,343 28.21
2025-03-05 80,879 364,099 22.21

(click for more detail)

Similar Companies
ACRS – Aclaris Therapeutics, Inc. ACT – Enact Holdings, Inc.
ADPT – Adaptive Biotechnologies Corporation AKRO – Akero Therapeutics, Inc.
ALEC – Alector, Inc.


Financial data and stock pages provided by
Fintel.io